GHC vs. APYX

Last updated Jun 4, 2026

GHC (Graham Holdings Company) and APYX (Apyx Medical Corporation) are both stocks. GHC operates in Education & Training Services (Consumer Defensive), while APYX operates in Medical Devices (Healthcare). Over the past 5 years, GHC returned 11.56%/yr vs -17.19%/yr for APYX. At a 0.21 correlation, their price movements are largely independent.

Performance

GHC vs. APYX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Graham Holdings Company (GHC) and Apyx Medical Corporation (APYX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GHC achieves a 0.50% return, which is significantly lower than APYX's 8.29% return.

GHC

• 1D: -0.52%
• 1M: -1.73%
• YTD: 0.50%
• 6M: -0.44%
• 1Y: 14.84%
• 3Y*: 24.52%
• 5Y*: 11.56%
• 10Y*: 9.16%

APYX

• 1D: -1.56%
• 1M: 32.98%
• YTD: 8.29%
• 6M: -5.25%
• 1Y: 133.95%
• 3Y*: -17.42%
• 5Y*: -17.19%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GHC vs. APYX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
GHC Graham Holdings Company	0.50%	26.98%	26.32%	16.56%	-3.02%	19.25%	-15.32%	-1.32%
APYX Apyx Medical Corporation	8.29%	121.52%	-39.69%	11.97%	-81.75%	78.06%	-14.89%	26.46%

Correlation

The correlation between GHC and APYX is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.20
Correlation (All Time) Calculated using the full available price history since Jan 3, 2019	0.21

Fundamentals

EPS GHC : $90.63 APYX : -$0.30
PS Ratio GHC : 0.96 APYX : 2.10
Total Revenue (TTM) GHC : $3.75B APYX : $55.83M
Gross Profit (TTM) GHC : $1.10B APYX : $21.29M
EBITDA (TTM) GHC : $722.08M APYX : -$3.18M

Return for Risk

GHC vs. APYX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GHC

GHC Risk / Return Rank: 56
GHC Sharpe Ratio Rank: 60
GHC Sortino Ratio Rank: 52
GHC Omega Ratio Rank: 52
GHC Calmar Ratio Rank: 57
GHC Martin Ratio Rank: 59

APYX

APYX Risk / Return Rank: 82
APYX Sharpe Ratio Rank: 82
APYX Sortino Ratio Rank: 81
APYX Omega Ratio Rank: 78
APYX Calmar Ratio Rank: 86
APYX Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GHC vs. APYX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Graham Holdings Company (GHC) and Apyx Medical Corporation (APYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GHC	APYX	Difference
Sharpe ratio: Return per unit of total volatility	0.56	1.53	-0.97
Sortino ratio: Return per unit of downside risk	0.95	2.44	-1.49
Omega ratio: Gain probability vs. loss probability	1.12	1.29	-0.17
Calmar ratio: Return relative to maximum drawdown	0.75	3.68	-2.93
Martin ratio: Return relative to average drawdown	1.99	8.93	-6.94
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GHC vs. APYX - Sharpe Ratio Comparison

The current GHC Sharpe Ratio is 0.56, which is lower than the APYX Sharpe Ratio of 1.53. The chart below compares the historical Sharpe Ratios of GHC and APYX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GHC	APYX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.56	1.53	-0.97
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.45	-0.17	+0.62
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.32	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.27	-0.08	+0.35

Drawdowns

GHC vs. APYX - Drawdown Comparison

The maximum GHC drawdown since its inception was -67.54%, smaller than the maximum APYX drawdown of -94.99%. Use the drawdown chart below to compare losses from any high point for GHC and APYX.

Drawdown Indicators

	GHC	APYX	Difference
Max Drawdown Largest peak-to-trough decline	-67.54%	-94.99%	+27.45%
Max Drawdown (1Y) Largest decline over 1 year	-19.78%	-36.59%	+16.81%
Max Drawdown (3Y) Largest decline over 3 years	-19.78%	-88.52%	+68.74%
Max Drawdown (5Y) Largest decline over 5 years	-20.79%	-94.99%	+74.20%
Max Drawdown (10Y) Largest decline over 10 years	-62.55%	—	—
Current Drawdown Current decline from peak	-7.51%	-78.22%	+70.71%
Average Drawdown Average peak-to-trough decline	-19.31%	-56.94%	+37.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.48%	15.06%	-7.58%

Volatility

GHC vs. APYX - Volatility Comparison

The current volatility for Graham Holdings Company (GHC) is 5.64%, while Apyx Medical Corporation (APYX) has a volatility of 31.94%. This indicates that GHC experiences smaller price fluctuations and is considered to be less risky than APYX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GHC	APYX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.64%	31.94%	-26.30%
Volatility (6M) Calculated over the trailing 6-month period	15.98%	52.34%	-36.36%
Volatility (1Y) Calculated over the trailing 1-year period	26.52%	88.10%	-61.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.06%	100.02%	-73.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.27%	92.93%	-64.66%

Dividends

GHC vs. APYX - Dividend Comparison

GHC's dividend yield for the trailing twelve months is around 0.67%, while APYX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
APYX Apyx Medical Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
GHC Graham Holdings Company	0.67%	0.66%	0.79%	0.95%	1.05%	0.96%	1.09%	0.87%	0.83%	0.91%	0.95%	89.61%

Financials

Frequently Asked Questions

Can I hold both GHC and APYX in my portfolio?

GHC and APYX have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, GHC or APYX?

APYX has higher volatility (31.94%) compared to GHC (5.64%). In terms of maximum drawdown, GHC dropped -67.54% vs APYX's -94.99%.

Which has better risk-adjusted returns?

APYX currently has the higher Sharpe Ratio (1.53 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.